CRISPR Therapeutics AG Common SharesCRSP
Close of Friday, October 23, 2026 · CRISPR Therapeutics AG Common Shares is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$49.39
vs its Pivot
-6.8%
OnlyAlpha Score
30
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -11.3% | -5.8% | -25.8% | +6.9% | -12.6% |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 0.36%IWM · 0.17%
Suppliers, customers and partners
CRSP sells to
| Vertex Pharmaceuticals | $205.0M upfront+milestones (diabetes license) |
Partners and deals
| Vertex Pharmaceuticals | CASGEVY profit 60/40 |
| Sirius Therapeutics (private) | siRNA partnership |
From the companies' own annual reports filed with the SEC.
Healthcare · Biotech
Get CRSP in your free daily emailAfter every close: whether CRSP is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track CRSP free → Full Stock check
Track CRSP free → Full Stock check